Clinical Trial: CIC101-02-LT is a Long-term Follow-up Study of Subjects Treated With TRTP-101 and Will Evaluate the Long-term Safety and Efficacy of TRTP-101.

U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07892937) titled 'CIC101-02-LT is a Long-term Follow-up Study of Subjects Treated With TRTP-101 and Will Evaluate the Long-term Safety and Efficacy of TRTP-101.' on Oct. 19.

Brief Summary: CIC101-02-LT is a long-term follow-up study of subjects treated with TRTP-101 and will evaluate the long-term safety and efficacy of TRTP-101.

Study Start Date: March 31, 2027

Study Type: OBSERVATIONAL

Condition: Atrophic Scar

Recruitment Status: NOT_YET_RECRUITING

Sponsor: CellinCells

Disclaimer: Curated by HT Syndication....